| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |